Home/Filings/4/0001156039-24-000029
4//SEC Filing

Haytaian Peter D 4

Accession 0001156039-24-000029

CIK 0001156039other

Filed

Mar 4, 7:00 PM ET

Accepted

Mar 5, 4:24 PM ET

Size

18.8 KB

Accession

0001156039-24-000029

Insider Transaction Report

Form 4
Period: 2024-03-01
Haytaian Peter D
EVP & Pres., Govt. Bus. Div.
Transactions
  • Tax Payment

    Common Stock

    2024-03-01$499.11/sh4,314$2,153,16113,425 total
  • Award

    Common Stock

    2024-03-01+2,40515,830 total
  • Award

    Common Stock

    2024-03-01+9,15224,982 total
  • Exercise/Conversion

    Common Stock

    2024-03-04$166.97/sh+15,000$2,504,55039,982 total
  • Sale

    Common Stock

    2024-03-04$500.18/sh4,206$2,103,75735,776 total
  • Sale

    Common Stock

    2024-03-04$500.18/sh1,889$944,84033,887 total
  • Sale

    Common Stock

    2024-03-04$500.18/sh15,000$7,502,70018,887 total
  • Award

    Employee Stock Option (Right to Buy)

    2024-03-01+9,2809,280 total
    Exercise: $499.11Exp: 2034-03-01Common Stock (9,280 underlying)
  • Exercise/Conversion

    Employee Stock Option (Right to Buy)

    2024-03-0415,0004,908 total
    Exercise: $166.97Exp: 2027-03-01Common Stock (15,000 underlying)
Footnotes (7)
  • [F1]PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK.
  • [F2]Represents restricted share units. Restrictions lapse as follows:801 shares on 3/1/2025, and 802 shares each on 3/1/2026 and 3/1/2027.
  • [F3]Represents performance based restricted share units. Restrictions lapse on 3/1/2024.
  • [F4]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 4, 2023.
  • [F5]This transaction was executed in multiple trades, each at the same price of $500.18. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares at which the transaction was effected.
  • [F6]The option represents a right to purchase a total of 9,280 shares, and is exercisable in two installments of 3,093 shares each, and one installment of 3,094 shares, beginning on 3/1/2025, which is the one-year anniversary of the option grant date.
  • [F7]The option represents a right to purchase a total of 19,908 shares and is exercisable in six semi-annual installments of 3,318 shares each beginning on 9/1/2017, which is the six-month anniversary of the date on which the option was granted.

Issuer

Elevance Health, Inc.

CIK 0001156039

Entity typeother

Related Parties

1
  • filerCIK 0001608538

Filing Metadata

Form type
4
Filed
Mar 4, 7:00 PM ET
Accepted
Mar 5, 4:24 PM ET
Size
18.8 KB